| Literature DB >> 19623653 |
Zhe Jin1, Daisuke Nagakubo, Aiko-Konno Shirakawa, Takashi Nakayama, Akiko Shigeta, Kunio Hieshima, Yasuaki Yamada, Osamu Yoshie.
Abstract
Human T-lymphotropic virus type 1 (HTLV-1), the etiological agent of adult T-cell leukemia (ATL), encodes the potent transcriptional activator Tax, which is required for HTLV-1-induced immortalization of T cells. CXCR7 is an atypical chemokine receptor frequently expressed by tumor cells and known to promote cell growth and survival. We found that HTLV-1-immortalized T cells expressing Tax consistently expressed CXCR7. Induction of Tax in JPX-9 upregulated CXCR7. Wild-type Tax efficiently activated the CXCR7 promoter via a proximal NF-kappaB site, while a mutant Tax selectively defective in NF-kappaB activation did not. CCX754, a synthetic CXCR7 antagonist, inhibited cell growth and increased apoptosis of HTLV-1-immortalized T cells. Knockdown of CXCR7 by small interfering RNA also reduced cell growth. Stable expression of CXCR7 in a CXCR7-negative ATL cell line promoted cell growth and survival. Taken together, CXCR7 is inducible by Tax and may play an important role in HTLV-1-induced immortalization of T cells by promoting growth and survival of HTLV-1-infected T cells. (c) 2009 UICC.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19623653 DOI: 10.1002/ijc.24612
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.396